skip navigation

S M L Text size
Home » Age-Related Eye Disease Study--Results
NEI and AREDS logos

Age-Related Eye Disease Study--Results

The Age-Related Eye Disease Study (AREDS) is a major clinical trial sponsored by the National Eye Institute, one of the Federal government's National Institutes of Health.

The AREDS was designed to:

Results from the AREDS showed that high levels of antioxidants and zinc significantly reduce the risk of advanced age-related macular degeneration (AMD) and its associated vision loss. These same nutrients had no significant effect on the development or progression of cataract.

The NEI has launched the Age-Related Eye Disease Study 2 (AREDS2). Nearly 100 clinical centers are now seeking 4,000 study participants ages 50 - 85 who have AMD. Learn more about AREDS2.


Summary of AREDS Results

Frequently Asked Questions

 

Bookmark or share this page

This page was last modified in October 2008

U. S. Department of Health and Human Services

National Institutes of Health

USA.gov